UnitedHealth Group Incorporated (UNH) Q1 2025 Earnings Call Transcript

UnitedHealth Group Incorporated (NYSE:UNH) Q1 2025 Results Conference Call April 17, 2025 8:45 AM ET

Company Participants

Andrew Witty – Chief Executive Officer
John Rex – Chief Financial Officer
Tim Noel – Chief Executive Officer, UnitedHealthcare Medicare & Retirement
Amar Desai – Chief Executive Officer, Optum Health
Heather Cianfrocco – Chief Executive Officer, Optum
Patrick Conway – Chief Executive Officer, Optum Rx
Krista Nelson – Chief Executive Officer, Community & State
Bobby Hunter – President, Medicare

Conference Call Participants

Justin Lake – Wolfe Research
Josh Raskin – Nephron Research
A.J. Rice – UBS
Lisa Gill – JPMorgan
Stephen Baxter – Wells Fargo
Erin Wright – Morgan Stanley
Andrew Mok – Barclays
Dave Windley – Jefferies
Ben Hendrix – RBC Capital Markets
Lance Wilkes – Bernstein
Sarah James – Cantor Fitzgerald
Jessica Tassan – Piper Sandler

Operator

Good morning, and welcome to the UnitedHealth Group First Quarter 2025 Earnings Conference Call. A question-and-answer session will follow UnitedHealth Group’s prepared remarks. As a reminder, this call is being recorded.

Here are some important introductory information. This call contains forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings.

This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the Financial and Earnings Reports section of the company’s Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K dated April 17, 2025, which may be accessed from the Investor Relations